Skip to main content

C-Max, Biomedica Nutraceuticals Pty Ltd, CON-986

Product name
C-Max
Sponsor name
Biomedica Nutraceuticals Pty Ltd
Batches
37466B
Consent start
Consent no.
CON-986
Standard
Therapeutic Goods Order No. 101 - Standard for Tablets, Capsules and Pills (TGO 101) Order 2019
Non-compliance with standard
The product does not comply because the estimated average content of Zinc is 141.0% of the label claim. As a result, this is outside the upper limit of the TGO 101 Schedule 2 requirements for the content of a mineral in a listed product of 90.0 - 125.0%.
Conditions imposed
The content of Zinc for the stated  batch/es must be no less than 90% and no more than 141.0% of the stated content on the label. 
Therapeutic product type
Listed complementary medicines

Help us improve the Therapeutic Goods Administration site